GNC Advances Joint Health Innovation with TamaFlex

Published: Oct 11, 2018

 

PITTSBURGH, /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC), a leading specialty health, wellness, and performance brand, today announced the launch and global exclusivity of TamaFlex, a potent botanical blend proven effective in improving joint health. The ingredient will be featured in three newly introduced products: TamaFlex, TamaFlex Fast Acting, and TamaFlex Complete.

"With TamaFlex, we are bringing innovation to a category that has otherwise been stagnant for nearly a decade," said Ken Martindale, chairman and CEO of GNC. "This launch positions GNC to tap into a $725 million domestic market, as well as drive new revenue streams and customer acquisitions across all channels."  

The traditional joint health market, has seen single digit declines year-over-year for more than ten years, and the market has been increasingly shifting toward more natural ingredients. For example, sales of turmeric-based supplements for joint health and inflammation have grown nearly $60 million over the past five years.

TamaFlex has clinically proven benefits, offering consumers a noticeable improvement in their level of joint discomfort. The ingredient combines two natural herbal botanicals, turmeric and tamarind seeds, is non-GMO, and contains no artificial colors or flavors.

TamaFlex will be introduced across three new products:

  • TamaFlex: Represents a breakthrough in joint health and comfort, with noticeable improvements in joint comfort (6X), joint function (7.5X), and in joint stiffness by 300 percent in as little as two weeks.
  • TamaFlex Fast-Acting: Designed to help customers feel the difference in 5 days, TamaFlex Fast Acting helps fight joint discomfort brought on by daily activities like walking, climbing stairs, and exercising. Backed by clinical science, the herbal blends in TamaFlex Fast Acting show improvements in joint comfort (7X), joint function (7.5X), and joint stiffness (5X).
  • TamaFlex Complete: Combines TamaFlex and hyaluronic acid with clinical strength doses of glucosamine, chondroitin and UC-II collagen, for the most comprehensive support available. 

TamaFlex Fast-Acting and TamaFlex Complete will be available exclusively at GNC retail locations and online. To learn more about the product line, visit https://www.gnc.com/brand/tamaflex.  

About GNC

GNC Holdings, Inc.  (NYSE: GNC) - Headquartered in Pittsburgh, PA - is a leading global specialty health, wellness and performance retailer.

GNC connects customers to their best selves by offering a premium assortment of health, wellness and performance products, including protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized third-party brands.

GNC's diversified, multi-channel business model generates revenue from product sales through company-owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce and corporate partnerships. As of June 30, 2018, GNC had approximately 8,800 locations, of which approximately 6,600 retail locations are in the United States (including approximately 2,400 Rite Aid franchise store-within-a-store locations) and franchise operations in approximately 50 countries.

Media Contact

GNC Media, GNCMedia@zenogroup.com, 212-284-0455

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/gnc-advances-joint-health-innovation-with-tamaflex-300729372.html

SOURCE GNC Holdings, Inc.

 
 
Company Codes: NYSE:GNC
 

Back to news